Hedge Fund - Biotechnology Value Fund / BVF Inc
Kymera Therapeutics Inc. (KYMR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $207,659,254 | 7.03% | 5,161,801 | $45.17 |
| 2 | 2024 - Q3 (2024-09-30) | $244,308,041 | 7.14% | 5,161,801 | $44.16 |
| 3 | 2024 - Q2 (2024-06-30) | $154,079,760 | 4.31% | 5,161,801 | $34.62 |
| 4 | 2024 - Q1 (2024-03-31) | $207,504,400 | 5.7% | 5,161,801 | $35.78 |
| 5 | 2023 - Q4 (2023-12-31) | $131,419,453 | 3.28% | 5,161,801 | $17.88 |
| 6 | 2023 - Q3 (2023-09-30) | $65,872,156 | 1.77% | 4,739,004 | $20.10 |
| 7 | 2023 - Q2 (2023-06-30) | $108,949,702 | 3.03% | 4,739,004 | $28.65 |
| 8 | 2023 - Q1 (2023-03-31) | $140,416,689 | 5.13% | 4,739,004 | $32.25 |
| 9 | 2022 - Q4 (2022-12-31) | $117,127,396 | 4.94% | 4,692,604 | $26.66 |
| 10 | 2022 - Q3 (2022-09-30) | $102,158,000 | 4.21% | 4,692,604 | $26.36 |
| 11 | 2022 - Q2 (2022-06-30) | $81,492,000 | 3.93% | 4,138,758 | $23.36 |
| 12 | 2022 - Q1 (2022-03-31) | $151,787,000 | 6.07% | 3,586,658 | $42.23 |
| 13 | 2021 - Q4 (2021-12-31) | $201,940,000 | 7.32% | 3,180,658 | $58.25 |
| 14 | 2021 - Q3 (2021-09-30) | $186,832,000 | 7.28% | 3,180,658 | $57.98 |
| 15 | 2021 - Q2 (2021-06-30) | $127,587,000 | 4.78% | 2,630,658 | $43.41 |
| 16 | 2021 - Q1 (2021-03-31) | $102,227,000 | 3.83% | 2,630,658 | $60.19 |
| 17 | 2020 - Q4 (2020-12-31) | $163,101,000 | 6.41% | 2,630,658 | $48.78 |
| 18 | 2020 - Q3 (2020-09-30) | $84,997,000 | 4.62% | 2,630,658 | $30.53 |
The displayed share prices are average quarterly stock market prices.